Are you Dr. Oton?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 94 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
700 Delaware St
Davis Pavilion, Mc 4001
Denver, CO 80204Phone+1 303-436-6171Fax+1 303-436-3801- Is this information wrong?
Summary
- Dr. Ana Oton, MD is an oncologist in Denver, Colorado. She is currently licensed to practice medicine in Colorado and Pennsylvania. She is affiliated with Denver Health and is an Assistant Professor at University of Colorado School of Medicine.
Education & Training
UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2004 - 2007
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2001 - 2004
Central University of VenezuelaClass of 1998
Certifications & Licensure
CO State Medical License 2007 - 2025
PA State Medical License 2004 - 2007- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
- S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2008 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsDesmoid Tumors: A Comprehensive Review.Meryem Bektas, Timothy Bell, Shahnaz Khan, Brad Tumminello, Maria M Fernandez, Catriona Heyes, Ana B Oton> ;Advances in Therapy. 2023 Sep 1
- Disease and economic burden of surgery in desmoid tumors: a review.Maria M Fernandez, Timothy Bell, Brad Tumminello, Shahnaz Khan, Shengfan Zhou, Ana B Oton> ;Expert Review of Pharmacoeconomics & Outcomes Research. 2023 Apr 26
- 1 citationsTreatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United StatesLisa M. Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, Cliff Molife, Ana B Oton> ;Current Medical Research and Opinion. 2021 Feb 2
- Join now to see all
Press Mentions
Phase II Trial of Efatutazone Shows Challenge of Matching Treatment to PopulationApril 8th, 2014
Professional Memberships
- Member
Hospital Affiliations
Denver HealthDenver, Colorado
